Profund Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 6.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 19,073 shares of the healthcare conglomerate’s stock after selling 1,227 shares during the period. UnitedHealth Group makes up about 0.7% of Profund Advisors LLC’s portfolio, making the stock its 24th largest holding. Profund Advisors LLC’s holdings in UnitedHealth Group were worth $9,633,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Virtus ETF Advisers LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $718,000. Octavia Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 8.8% during the second quarter. Octavia Wealth Advisors LLC now owns 740 shares of the healthcare conglomerate’s stock worth $380,000 after purchasing an additional 60 shares in the last quarter. Arcus Capital Partners LLC lifted its holdings in UnitedHealth Group by 40.1% in the 3rd quarter. Arcus Capital Partners LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,241,000 after purchasing an additional 703 shares in the last quarter. Great Valley Advisor Group Inc. grew its holdings in shares of UnitedHealth Group by 41.8% during the second quarter. Great Valley Advisor Group Inc. now owns 26,614 shares of the healthcare conglomerate’s stock worth $13,670,000 after buying an additional 7,851 shares in the last quarter. Finally, Crumly & Associates Inc. boosted its position in UnitedHealth Group by 2.5% during the second quarter. Crumly & Associates Inc. now owns 1,578 shares of the healthcare conglomerate’s stock worth $810,000 after acquiring an additional 38 shares during the last quarter. 86.31% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on UNH shares. Royal Bank of Canada boosted their target price on UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a report on Monday, October 17th. Loop Capital upped their price objective on shares of UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. Morgan Stanley reissued an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research note on Wednesday, November 23rd. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $615.00 to $617.00 and gave the stock a “buy” rating in a research report on Tuesday. Finally, UBS Group lowered their price target on UnitedHealth Group from $590.00 to $550.00 and set a “neutral” rating for the company in a report on Wednesday, January 18th. Three research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $599.39.
UnitedHealth Group Stock Down 0.6 %
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, topping analysts’ consensus estimates of $5.17 by $0.17. The company had revenue of $82.79 billion during the quarter, compared to analysts’ expectations of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same period last year, the firm earned $4.48 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 24.9 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 13th. Shareholders of record on Monday, December 5th were issued a $1.65 dividend. The ex-dividend date was Friday, December 2nd. This represents a $6.60 dividend on an annualized basis and a yield of 1.35%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.15%.
Insider Transactions at UnitedHealth Group
In related news, EVP Erin Mcsweeney sold 450 shares of the business’s stock in a transaction dated Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total value of $244,035.00. Following the sale, the executive vice president now directly owns 8,736 shares in the company, valued at approximately $4,737,532.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.40% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- Is It Time To Get Aggressive With Defense Stocks?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.